Veritas Q1 2026: A Quality Book Halved by Outflows

Veritas Asset Management, the London-based concentrated-quality manager, reported a sharply smaller U.S. book in the first quarter of 2026 — and the way it shrank tells the story. Its reported 13F value fell 39.6% to $5.90 billion, the position count dropped from 27 to 21, and nearly every top holding was cut by a quarter to 40%: Amazon down 40%, Microsoft down 38%, Canadian Pacific down 27%, UnitedHealth down 26%, Salesforce down 24%, Thermo Fisher down 25%. That combination — fewer positions plus broad, proportional trims of the names it kept — is the signature of outflows, not a change in strategy.

When a concentrated fund must return capital to investors, it sells across its book to raise cash, producing exactly this pattern: a smaller book where the surviving holdings are all lighter. The businesses Veritas trimmed are the same high-quality compounders it has long favored, which is the giveaway that this is forced selling rather than a bearish reassessment.

Across-the-board trims

Amazon remains the largest holding at 9.24% of the book despite a 40% cut, with Canadian Pacific Kansas City (down 27%), UnitedHealth (down 26%), and a large foreign-listed position rounding out the top tier. Microsoft was cut 38%, Salesforce 24%, and Thermo Fisher 25%.

The uniformity is the tell. When a manager reduces most of its top positions by similar large percentages in one quarter, and the position count falls at the same time, it is almost always raising cash across the book rather than making a series of independent stock calls. These are quality names — exactly what a quality-focused manager wants to own — being lightened together.

The lone exception

One position bucked the trend. Mastercard was raised 35% to 9.0% of the book, even as nearly everything else was cut.

That add is the most informative line in the filing. When a fund is selling across its book to meet redemptions, the one name it chooses to increase reveals where its conviction is strongest — the holding it was willing to add to even while raising cash everywhere else. For Veritas, that was Mastercard, the payment-network compounder. The exception, against a backdrop of forced selling, is the real signal.

A two-year contraction

The trajectory confirms the outflow read.

Veritas's reported 13F value has fallen steadily from about $13.22 billion in mid-2024 to $5.90 billion — more than halving — with the steepest drop in the latest quarter. A concentrated quality fund whose value declines this consistently, while its holdings remain blue-chip compounders and its position count shrinks, is the textbook picture of sustained redemptions rather than a thesis gone wrong. The quality of what it owns did not change; the capital behind it did.

What it signals

For investors who track institutional positioning, Veritas's first-quarter filing is a case study in separating forced selling from conviction. The 40% cuts to Amazon and Microsoft are not bearish calls — they are what outflows look like at a concentrated fund. The genuine signal is the Mastercard add, the one place the manager leaned in while raising cash. The actionable lesson is a recurring one: when a book shrinks broadly and proportionally, read it as flows, and look to the lone exception for the real conviction.

FAQ

Why did Veritas's portfolio shrink so much in Q1 2026?
Its reported 13F value fell 39.6% to $5.90 billion, part of a decline from about $13.22 billion over two years. The broad, proportional cuts across high-quality holdings plus a falling position count are consistent with sustained investor outflows, not a change in strategy.

What did Veritas cut?
Nearly everything: Amazon down 40%, Microsoft down 38%, Canadian Pacific down 27%, UnitedHealth down 26%, Thermo Fisher down 25%, and Salesforce down 24% — broad reductions across its quality core.

Did Veritas add to anything?
Yes. Mastercard was raised 35% to 9.0% of the book — the lone meaningful add and the clearest signal of where the firm's conviction remains strongest even as it raised cash elsewhere.

Is Veritas bearish on its holdings?
Unlikely. The trimmed names are the high-quality compounders the strategy is built on. The across-the-board reductions reflect raising cash for outflows rather than a negative view on Amazon, Microsoft, or UnitedHealth.